Chemical Structure (Celebrex 01)
Vyscoxa Suspension
Product Images NDC 15370-501
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vyscoxa (NDC 15370-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carwin Pharmaceutical Associates, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (mg Bottle Label)
This text is from a medication label for VYSCOXA oral suspension containing celecoxib. Each mL of the suspension has 10 mg of celecoxib. It provides instructions on dosage, storage, and administration. The medication should be taken on an empty stomach. The label also has information on dispensing, storage requirements, and a warning to keep the medication out of the reach of children. The pharmacist should dispense it in a light-resistant container with a child-resistant closure. The medication guide should be dispensed with each order, and the suspension should be discarded 21 days after opening. It also mentions to discard after a specific date and to not use if the foil seal is broken or missing. The manufacturer is Carwin Pharmaceutical Associates, LLC located in Hazlet, NJ 07730.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
